Publications by authors named "Robert Freeborn"

Claim this Profile
F
From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases.
Yannick Bulliard, Robert Freeborn, Molly Javier Uyeda, Daryl Humes, Ryan Bjordahl

Front Immunol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML.
Ece Canan Sayitoglu, Bogdan A Luca, Allison Paige Boss, Benjamin Craig Thomas, Robert Arthur Freeborn

Leukemia· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arsenic trioxide inhibits the response of primary human B cells to influenza virus A in vitro.
Luca M Kaiser, Robert A Freeborn, Allison P Boss, Yining Jin, Cheryl E Rockwell

Toxicol In Vitro· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic signature and key transcriptional regulators of human antigen-specific type 1 regulatory T cells.
Alma-Martina Cepika, Laura Amaya, Colin Waichler, Mansi Narula, Michelle M Mantilla, Robert Arthur Freeborn

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-10 disrupts liver repair in acetaminophen-induced acute liver failure.
Katherine Roth, Jenna Strickland, Asmita Pant, Robert Freeborn, Rebekah Kennedy

Front Immunol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML.
Ece Canan Sayitoglu, Bogdan A Luca, Allison P Boss, Benjamin Craig Thomas, Robert Arthur Freeborn

bioRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 1 regulatory T cell-mediated tolerance in health and disease.
Robert A Freeborn, Steven Strubbe, Maria Grazia Roncarolo

Front Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trivalent arsenic impairs the effector response of human CD4 and CD8 T cells to influenza A virus ex vivo.
Robert A Freeborn, Allison P Boss, Luca M Kaiser, Elizabeth M Gardner, Cheryl E Rockwell

Food Chem Toxicol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Yin and Yang of Type 1 Regulatory T Cells: From Discovery to Clinical Application.
Ece Canan Sayitoglu, Robert Arthur Freeborn, Maria Grazia Roncarolo

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of Nrf2 in autoimmunity and infectious disease: Therapeutic possibilities.
Robert A Freeborn, Cheryl E Rockwell

Adv Pharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BHLHE40 Regulates IL-10 and IFN- Production in T Cells but Does Not Interfere With Human Type 1 Regulatory T Cell Differentiation.
Molly Javier Uyeda, Robert A Freeborn, Brandon Cieniewicz, Rosa Romano, Ping Pauline Chen

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic low-level cadmium exposure in rats affects cytokine production by activated T cells.
Alexandra E Turley, Joseph W Zagorski, Rebekah C Kennedy, Robert A Freeborn, Jenna K Bursley

Toxicol Res (Camb)· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Nrf2 activator tBHQ inhibits the activation of primary murine natural killer cells.
Allison P Boss, Robert A Freeborn, David M Duriancik, Rebekah C Kennedy, Elizabeth M Gardner

Food Chem Toxicol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of the Nrf2 activators tBHQ and CDDO-Im on the early events of T cell activation.
Joseph W Zagorski, Alexandra E Turley, Robert A Freeborn, Kelly R VanDenBerg, Heather E Dover

Biochem Pharmacol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of early T cell cytokine production by arsenic trioxide occurs independently of Nrf2.
Kelly R VanDenBerg, Robert A Freeborn, Sheng Liu, Rebekah C Kennedy, Joseph W Zagorski

PLoS One· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis